Literature DB >> 23746798

Fetal growth in women with homozygous sickle cell disease: an observational study.

Minerva M Thame1, Clive Osmond, Graham R Serjeant.   

Abstract

OBJECTIVES: To assess fetal growth and whether lower birthweight to mothers with homozygous sickle cell (SS) disease is related to maternal body composition or to clinical events in pregnancy. STUDY
DESIGN: A prospective study of 41 pregnant women with SS disease and 41 women with a normal (AA) phenotype attending the antenatal clinic, University Hospital of the West Indies, Kingston, Jamaica. Maternal anthropometry, body composition and fetal sonographic measurements were assessed at 15, 25, and 35 weeks' gestation from December 2005 to April 2008. Birth measurements were performed within 24h of delivery. Differences between maternal genotypes and between their offspring were assessed using 2-sample t-tests. Multiple linear regression was used to control for baby's gender and gestational age at delivery. Fetal growth was compared in SS mothers with and without admission for sickle-related complications including bone pain crisis, acute chest syndrome, pregnancy-induced hypertension and urinary tract infection.
RESULTS: Mothers with SS disease had lower weight, body fat, fat mass and lean body mass throughout pregnancy but correlation with birth size did not reach statistical significance. Sonographically, babies of SS mothers had smaller abdominal circumference, femoral length and a lower estimated fetal weight at 35 weeks. Birth measurements confirm lower birthweight, crown-heel length and head circumference but the differences were no longer significant after adjustment for baby gender and gestational age at delivery. Bone pain crisis in pregnancy was associated with a significantly reduced crown-heel length at birth.
CONCLUSION: Lower birthweight in babies of mothers with SS disease is largely the result of the lower gestational age. Fetal sonography showed no growth differences by maternal genotype until 35 weeks' gestation and a reduced crown-heel length in offspring of SS mothers was associated with bone pain crises in pregnancy.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Body composition; Fetal growth; Sickle cell disease

Mesh:

Year:  2013        PMID: 23746798     DOI: 10.1016/j.ejogrb.2013.04.013

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  5 in total

1.  Mildly raised tricuspid regurgitant velocity 2.5-3.0 m/s in pregnant women with sickle cell disease is not associated with poor obstetric outcome - An observational cross-sectional study.

Authors:  May C Soh; Srividhya Sankaran; Natali Ya Chung; Catherine Nelson-Piercy; Jo Howard; Sue E Robinson; Eugene Oteng-Ntim
Journal:  Obstet Med       Date:  2016-08-03

2.  Complications in pregnant women with sickle cell disease.

Authors:  Kim Smith-Whitley
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  Multidisciplinary care results in similar maternal and perinatal mortality rates for women with and without SCD in a low-resource setting.

Authors:  Samuel A Oppong; Eugenia V Asare; Edeghonghon Olayemi; Theodore Boafor; Yvonne Dei-Adomakoh; Alim Swarry-Deen; Enoch Mensah; Yvonne Osei-Bonsu; Selina Crabbe; Latif Musah; Charles Hayfron-Benjamin; Brittany Covert; Adetola A Kassim; Andra James; Mark Rodeghier; Carolyn Audet; Michael R DeBaun
Journal:  Am J Hematol       Date:  2018-12-05       Impact factor: 10.047

4.  Birth Weights in Sickle Cell Disease Pregnancies: A Cohort Study.

Authors:  Daveena Meeks; Susan E Robinson; David Macleod; Eugene Oteng-Ntim
Journal:  PLoS One       Date:  2016-10-24       Impact factor: 3.240

Review 5.  Pregnancy in the Sickle Cell Disease and Fetomaternal Outcomes in Different Sickle cell Genotypes: A Systematic Review and Meta-Analysis.

Authors:  Teamur Aghamolaei; Asiyeh Pormehr-Yabandeh; Zahra Hosseini; Nasibeh Roozbeh; Mahdieh Arian; Amin Ghanbarnezhad
Journal:  Ethiop J Health Sci       Date:  2022-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.